[HTML][HTML] Pharmacological treatments for cocaine craving: what is the way forward? A systematic review

DLS Lassi, A Malbergier, AB Negrão, L Florio… - Brain Sciences, 2022‏ - mdpi.com
Background: cocaine craving is a core feature of cocaine use disorder and remains a critical
challenge for abstinence and relapse prevention. This review summarizes the anti-craving …

A randomized placebo-controlled trial of targeted prefrontal cortex modulation with bilateral tDCS in patients with crack-cocaine dependence

EK Batista, J Klauss, F Fregni… - International journal …, 2015‏ - academic.oup.com
Background: Transcranial direct current stimulation over the dorsolateral prefrontal cortex
has been shown to be clinically useful in the treatment of drug addiction. Methods: We …

A threshold model for opposing actions of acetylcholine on reward behavior: molecular mechanisms and implications for treatment of substance abuse disorders

K Grasing - Behavioural brain research, 2016‏ - Elsevier
The cholinergic system plays important roles in both learning and addiction. Medications
that modify cholinergic tone can have pronounced effects on behaviors reinforced by natural …

Anti‐Parkinson Drug Biperiden Inhibits Enzyme Acetylcholinesterase

A Kostelnik, A Cegan… - BioMed research …, 2017‏ - Wiley Online Library
Biperiden is a drug used in Parkinson disease treatment and it serves also as an
antiseizures compound in organophosphates poisoning. It acts as antagonist of muscarinic …

Exploring the efficacy of cholinergic agents for the treatment of psychostimulant use disorder: a systematic review

N Salloum, M Chouchana, R Icick, V Bloch… - …, 2024‏ - Springer
Rationale No drugs are currently validated to treat psychostimulant use disorder (PUD).
Pathophysiological studies consistently highlight the contribution of cholinergic mechanisms …

Preliminary investigation of the administration of biperiden to reduce relapses in individuals with cocaine/crack user disorder: A randomized controlled clinical trial

MSC Junior, AG Bezerra, DF Curado… - Pharmacology …, 2024‏ - Elsevier
Background Several studies have demonstrated that ACh modulates the dopaminergic
circuit in the nucleus accumbens, and its blockade appears to be associated with the …

Safety and preliminary efficacy of the acetylcholinesterase inhibitor huperzine a as a treatment for cocaine use disorder

R De La Garza, CD Verrico, TF Newton… - International Journal …, 2016‏ - academic.oup.com
Background: Cholinergic transmission is altered by drugs of abuse and contributes to
psychostimulant reinforcement. In particular, acetylcholinesterase inhibitors, like huperzine …

Novel pharmacological agents for the treatment of cocaine use disorder

H Hadizadeh, J Flores, E Nunes, T Mayerson… - Current Behavioral …, 2022‏ - Springer
Abstract Purpose of Review This narrative review aims to summarize the literature on novel
pharmacological agents with potential for the treatment of cocaine use disorder. Recent …

Biperiden reverses the increase in 50-kHz ultrasonic vocalizations but not the increase in locomotor activity induced by cocaine

TCS Saldanha, WN Sanchez, P Palombo… - Behavioural Brain …, 2024‏ - Elsevier
Cocaine use disorder (CUD) is a worldwide public health problem, associated with severe
psychosocial and economic impacts. Currently, no FDA-approved treatment is available for …

Spending trends on neuropsychiatric drugs in Minas Gerais, Brazil: is the offer of anti-parkinson drugs increasing?

LMS Carvalho, JC Alves, TCB Luz - Ciência & Saúde Coletiva, 2021‏ - SciELO Brasil
Neuropsychiatric drugs are used for a wide variety of neurological and psychiatric
conditions. This article aims to analyze the trend and determinants of public expenditure of …